Skip to main content
. 2004 Jan 6;90(1):31–35. doi: 10.1038/sj.bjc.6601518

Table 1. Main patient characteristics.

Characteristics No of patients (%)
Total eligible 48
Age (years)  
 Median 50
 Range 40–68
   
WHO-PS  
 0 41 (85)
 1–2 7 (15)
   
Hormonal receptor status  
 Positive 29 (61)
 Negative 14 (29)
 Unknown 5 (10)
   
Dominant metastatic site  
 Viscera 34 (71)
 Soft tissue 14 (29)
   
Bone metastases 23 (48)
Number of metastatic sites  
 1 11 (23)
 2 23 (48)
 3 14 (29)
   
Previous therapies  
 Adjuvant chemotherapy (All) 24 (50)
 Adjuvant anthracyclin 5 (10)
 Adjuvant hormonotherapy 18 (38)
 Prior hormonotherapy for metastatic disease 5 (10)